Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth A Miles

Showing results (31-40 of 41) with videos related to

Pageof 5
Sort By:
Molecular Imaging|September 8, 2012
Integrated 18F-fluorodeoxyglucose-positron emission tomography/dynamic contrast-enhanced computed tomography to phenotype non-small cell lung carcinomaManu Shastry, Kenneth A Miles, Thida Win, et al.
Nuclear Medicine Communications|July 16, 2014
Old tracer for a new purpose: potential role for 99mTc-2-Methoxyisobutylisonitrile (99mTc-MIBI) in renal transplant careSabina Dizdarevic, Mark Aplin, Melanie J Newport, et al.
Insights Into Imaging|October 25, 2012
Assessment of tumor heterogeneity: an emerging imaging tool for clinical practice?Fergus Davnall, Connie S P Yip, Gunnar Ljungqvist, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 17, 2010
¹⁸F-FDG PET and biomarkers for tumour angiogenesis in early breast cancerAshley M Groves, Manu Shastry, Manuel Rodriguez-Justo, et al.
European Journal of Nuclear Medicine and Molecular Imaging|September 27, 2008
Metabolic-flow relationships in primary breast cancer: feasibility of combined PET/dynamic contrast-enhanced CTAshley M Groves, Gordon C Wishart, Manu Shastry, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 11, 2013
Tumor heterogeneity and permeability as measured on the CT component of PET/CT predict survival in patients with non-small cell lung cancerThida Win, Kenneth A Miles, Sam M Janes, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 12, 2014
Multifunctional imaging signature for V-KI-RAS2 Kirsten rat sarcoma viral oncogene homolog (KRAS) mutations in colorectal cancerKenneth A Miles, Balaji Ganeshan, Manuel Rodriguez-Justo, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 6, 2025
Texture analysis of [<sup>18</sup>F]FDG PET/CT may stratify risk in stage II colorectal cancer - discovery findingsLouise Rice, Balaji Ganeshan, Simon Wan, et al.
Health Technology Assessment (Winchester, England)|March 15, 2022
Dynamic contrast-enhanced CT compared with positron emission tomography CT to characterise solitary pulmonary nodules: the SPUtNIk diagnostic accuracy study and economic modellingFiona J Gilbert, Scott Harris, Kenneth A Miles, et al.
Thorax|December 10, 2021
Comparative accuracy and cost-effectiveness of dynamic contrast-enhanced CT and positron emission tomography in the characterisation of solitary pulmonary nodulesFiona J Gilbert, Scott Harris, Kenneth A Miles, et al.
Pageof 5

Showing results (31-40 of 41) with videos related to

Sort By:
Pageof 5
Molecular Imaging|September 8, 2012
Integrated 18F-fluorodeoxyglucose-positron emission tomography/dynamic contrast-enhanced computed tomography to phenotype non-small cell lung carcinomaManu Shastry, Kenneth A Miles, Thida Win, et al.
Nuclear Medicine Communications|July 16, 2014
Old tracer for a new purpose: potential role for 99mTc-2-Methoxyisobutylisonitrile (99mTc-MIBI) in renal transplant careSabina Dizdarevic, Mark Aplin, Melanie J Newport, et al.
Insights Into Imaging|October 25, 2012
Assessment of tumor heterogeneity: an emerging imaging tool for clinical practice?Fergus Davnall, Connie S P Yip, Gunnar Ljungqvist, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 17, 2010
¹⁸F-FDG PET and biomarkers for tumour angiogenesis in early breast cancerAshley M Groves, Manu Shastry, Manuel Rodriguez-Justo, et al.
European Journal of Nuclear Medicine and Molecular Imaging|September 27, 2008
Metabolic-flow relationships in primary breast cancer: feasibility of combined PET/dynamic contrast-enhanced CTAshley M Groves, Gordon C Wishart, Manu Shastry, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 11, 2013
Tumor heterogeneity and permeability as measured on the CT component of PET/CT predict survival in patients with non-small cell lung cancerThida Win, Kenneth A Miles, Sam M Janes, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 12, 2014
Multifunctional imaging signature for V-KI-RAS2 Kirsten rat sarcoma viral oncogene homolog (KRAS) mutations in colorectal cancerKenneth A Miles, Balaji Ganeshan, Manuel Rodriguez-Justo, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 6, 2025
Texture analysis of [<sup>18</sup>F]FDG PET/CT may stratify risk in stage II colorectal cancer - discovery findingsLouise Rice, Balaji Ganeshan, Simon Wan, et al.
Health Technology Assessment (Winchester, England)|March 15, 2022
Dynamic contrast-enhanced CT compared with positron emission tomography CT to characterise solitary pulmonary nodules: the SPUtNIk diagnostic accuracy study and economic modellingFiona J Gilbert, Scott Harris, Kenneth A Miles, et al.
Thorax|December 10, 2021
Comparative accuracy and cost-effectiveness of dynamic contrast-enhanced CT and positron emission tomography in the characterisation of solitary pulmonary nodulesFiona J Gilbert, Scott Harris, Kenneth A Miles, et al.
Pageof 5